|Bid||11.15 x 800|
|Ask||11.25 x 1400|
|Day's Range||10.14 - 11.31|
|52 Week Range||8.75 - 101.39|
|Beta (5Y Monthly)||1.88|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 27, 2023 - Mar 03, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||81.33|
Is Novavax stock a buy as the company plans to update its Covid shot, in line with FDA experts' advice? Is NVAX stock a buy right now?
Novavax (NASDAQ: NVAX) has offered investors just such a ride over the past few years. Initial gains came as investors bet on Novavax's chances of bringing a coronavirus vaccine to market; declines occurred after the vaccine entered the market later than rival products did. Now, as we start a new year, you might be wondering what to do about Novavax.
Pfizer/BioNTech, Moderna and Novavax are included in this Analyst Blog.